Impact of Continuous Positive Airway Pressure on Epicardial Adipose Tissue in Patients with Obstructive Sleep Apnea

Impact of Continuous Positive Airway Pressure on Epicardial Adipose Tissue in Patients with Obstructive Sleep Apnea - Impact of CPAP on Epicardial Adipose Tissue in OSAS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013924

Enrollment

Registered

2014-07-01

Start date

2014-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Scheduled to undergo polysomnography 2. Cardiac CT is avairable

Exclusion criteria

Exclusion criteria: 1. Current or previous treatments for obstructive sleep apnea 2. Central sleep apnea syndrome 3. Unable to use CPAP 4. Hope for treatments other than CPAP 5. Scheduled to have special treatment or program for body weight reduction 6. Wearing a pacemaker

Design outcomes

Primary

Measure	Time frame
The change in the volume of epicardial adipose tissue (measured by cardiac CT) during a 1-year CPAP treatment for OSA.	—

Secondary

Measure	Time frame
1. The change in body weight and body composition 2. The progression of coronary arterty disease 3. The recurrence of arrythmia 4. The change in leptin/adiponectin 5. The change in serum lipid level	—

Countries

Japan

Contacts

Public ContactRyo Tachikawa

Graduate school of medicine, Kyoto University Respiratory medicine

ryotkw@gmail.com075-751-3852

Outcome results